Advertisement
Screener

TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Net Margin

TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Net Margin

  • 2026-06-30: Net Margin -299.41%.
  • 2026-03-31: Net Margin -584.38%.
  • 2025-12-31: Net Margin -870.32%.
  • 2025-09-30: Net Margin -972.95%.

Complete source-backed net margin history.

Available history
2023-09-30 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-299.41%
2026-03-31-584.38%
2025-12-31-870.32%
2025-09-30-972.95%
2025-06-30-1415.02%
2025-03-31-692.84%
2024-12-31-856.24%
2024-09-30-503.65%
2024-06-30-3567.75%
2024-03-31-601.89%
2023-12-31-723.00%
2023-09-30-701.30%

Annual Net Margin

DateNet Margin
2025-12-31-946.22%
2024-12-31-1288.25%
2023-12-31-1501.78%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Minerva Neurosciences, Inc. (NERV)United States$0.165B-0.66
ADC Therapeutics SA (ADCT)$0.163B-1.39
LIFECORE BIOMEDICAL, INC. DE (LFCR)United States$0.163B-8.50
Organogenesis Holdings Inc. (ORGO)United States$0.182B-3.70
AN2 Therapeutics, Inc. (ANTX)United States$0.185B-4.84
Annexon, Inc. (ANNX)United States$0.147B-4.22
PepGen Inc. (PEPG)United States$0.186B-1.73
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72
ALX ONCOLOGY HOLDINGS INC (ALXO)United States$0.187B-3.52
Fortress Biotech, Inc. (FBIO)United States$0.188B0.91